Delivery Order SPE2DB22D1017-SPE2DB23FF8XZ
Award Date 6/23/23
Potential Completion Date 6/26/23
Potential Value $78
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $73,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 tablets of 10mg amlodipine besylate. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support Defense Logistics Agency procurement programs. No major subcontractors or set aside designations were identified. The delivery order has a period of performance from July 10-11, 2023 to fulfill the Defense Logistics...
- The Defense Logistics Agency awarded a $4,890 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 tablets of 2.5 mg amlodipine besylate. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The one-day order runs from August 7-8, 2023 under the parent company Amerisourcebergen Corporation's indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were indicated. The Defense Logistics...
- The Defense Logistics Agency awarded a $21,680 delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 2.5 mg amlodipine besylate. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania for delivery by September 11, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing contract vehicle. The prime contractor will provide the pharmaceutical...
- The Defense Logistics Agency awarded a $5,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 2.5 mg amlodipine besylate. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility by September 1, 2023 in support of the Defense Logistics Agency's medical supply needs. No additional details were provided regarding the solicitation or any overarching contracts under which this delivery order was issued.
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $47,640 to Amerisourcebergen Drug Corporation for 1,000 tablets of amlodipine besylate 5 mg. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is from August 17 to August 18, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a common hypertension medication supports the Defense Logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $134,000 to Amerisourcebergen Drug Corporation for 1,000 tablets of 10mg amlodipine besylate. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania within the period of performance between August 8-9, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely...
- The Defense Logistics Agency awarded a $58,560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 tablets of 10 mg amlodipine besylate. The prime contractor will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by September 15, 2023 in support of the Defense Logistics Agency's medical supply needs. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
- The Defense Logistics Agency awarded a $171,480 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 boxes of 10mg amlodipine besylate tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility by September 19, 2023 in support of the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were indicated. The delivery order was issued against an existing DLA...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $634 to AmerisourceBergen Drug Corporation for 1,000 tablets of 10 mg amlodipine besylate. The order is to be fulfilled by AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with performance required between September 8-11, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the global supply chain for the U.S. military and supports its...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $414.35 to Amerisourcebergen Drug Corporation for 1,000 tablets of 10mg amlodipine besylate. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the specified...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FF8XZDelivery Order
The Defense Logistics Agency awarded a $78,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 2.5 mg amlodipine besylate per package. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning from June 23, 2023 to June 26, 2023 to fulfill the Defense Logistics Agency's requirements for this pharmaceutical product. No major subcontractors or set aside designations were indicated in the award information.
Generated 12/17/23, 11:29 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $78 | 6/23/23 |